Revenue growth of nine percent expected in 2025, down nearly 10 percentage points from September 2024 Research and development innovation...
Investments
2024 shaping up to be a strong year for biopharma SAN FRANCISCO, Aug. 7, 2024 /PRNewswire/ -- In the first half...